Strategic Investments and Adjusted Gross Margin Report
•
STRATEGIC INVESTMENTS IN INNOVATION
Organigram has a track-record of first-to-market innovations and is positioned to realize defensible competitive
advantages from investments in technology
First-to-market Successes
Milled flower with custom flavour blends introduced under
Organigram's highly successful SHRED brand
Patent pending Rip-Strip hash - a revolutionary new way for
consumers to experience Hash
Edison JOLTS-the first patented ingestible extract
introduced to the Canadian consumer
Canada's only whole-flower derived THCV portfolio - THCV
is a minor cannabinoid touted for its appetite suppressing
qualities
EDISON
SHREDEMS
GUAVA LIME GO-TIME
ng THC 10 mg THCV PER PACK
SATION GUAMARS
EDISON
JOLTS
ELECTRIC
LEMON
SATIVA LOZENGES
JOLTS
FRESHLY
MINTED
SATIVA LOZENGES
SHREDX
RIP-STRIP HASH
10 STRIPS |2g|35%+ THC
100
00
blueberry
blaster
nder
•
.
•
Growing Portfolio of
Competitive Technologies
The PDC is in the late-stage development of product
innovations which are planned to be applied to certain
products within Organigram's portfolio in calendar 2024
Organigram's facility CAPEX projects focused on production
& packaging automation and internalizing testing &
remediation are complete and expect to realize annual cost
savings in F2024
Investment in Green Tank Technologies Corp. ("Greentank")
vaporization hardware to solve pain points in flavour
performance and clogging
Investment in US-based Phylos Bioscience Inc. ("Phylos")
provides exclusive access to high-THCV cultivars and
technical know-how. As a result, Organigram has begun
transitioning a portion of its grow rooms to cost-effective,
seed-based production, and this is expected to yield more
robust and consistent harvests while reducing grow time
and production costs
ORGANIGRAM
12
12View entire presentation